Atorvastatin Calcium Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute Myocardial Infarction
Conditions: Plaque, Atherosclerotic Interventions: Drug: atorvastatin; Procedure: IVUS/OCT; Drug: inclisiran Sponsors: Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Improving Cardiovascular Health Risks in Adults With Epilepsy on a Modified Atkins Diet
Conditions: Epilepsy; Dyslipidemia Interventions: Drug: Atorvastatin 10mg; Other: Modification of dietary fat composition Sponsors: Johns Hopkins University; American Heart Association Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Effects of PCSK-9 Inhibitor Treatment Prior to Undergoing Primary Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction
Conditions: STEMI Interventions: Drug: evolocumab; Drug: Atorvastatin Sponsors: Beijing Luhe Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke
Conditions: Ischemic Stroke Interventions: Drug: Atorvastatin 40 Mg Oral Tablet; Drug: Rosuvastatin 20mg Sponsors: Kafrelsheikh University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Minor Stroke or TIA
Conditions: Ischemic Stroke Interventions: Drug: Atorvastatin 40mg; Drug: Rosuvastatin 20mg Sponsors: Kafrelsheikh University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
Clinical effects of atorvastatin combined with conbercept in the treatment of patients with macular edema secondary to retinal vein occlusion and carotid plaque: study protocol for a prospective randomized controlled trial
This study aims to observe the clinical effects of atorvastatin and intravitreal therapy in the treatment of patients with branch or central RVO-ME and coexistent carotid plaques (CP).Methods and analysisA prospective randomized controlled clinical trial will be conducted. Sixty-four patients diagnosed with branch or central RVO-ME and coexistent CP will be enrolled and randomly allocated in a 1:1 ratio to the control and experimental groups. The control group will be treated with intravitreal conbercept monthly for 3 months, followed by monthly evaluation and injection of pro re nata (PRN) for 12 months, while the experim...
Source: Trials - April 8, 2024 Category: Research Source Type: clinical trials
Cognitive Decline and Underlying Mechanisms in Symptomatic Intracranial Artery Stenosis Patients: A Cohort Study
Conditions: Intracranial Atherosclerosis; Cognitive Impairment; Cerebrovascular Event Interventions: Drug: Aspirin Tablet, Clopidogrel Bisulfate Tablets and Atorvastatin; Procedure: Endovascular therapy,Aspirin Tablet, Clopidogrel Bisulfate Tablets and Atorvastatin Sponsors: Anhui Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma
Conditions: Glioblastoma, IDH-wildtype Interventions: Drug: Atorvastatin 20mg Sponsors: Tianjin Medical University General Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
Novel Approaches for Improving Vascular Function in Veterans With HFpEF
Conditions: HFpEF - Heart Failure With Preserved Ejection Fraction; Inflammation Interventions: Drug: L-Citrulline then Placebo; Drug: Placebo then L-Citrulline; Drug: BH4 then Placebo; Drug: Placebo then BH4; Drug: Atorvastatin then Placebo; Drug: Placebo then Atorvastatin Sponsors: D. Walter Wray; US Department of Veterans Affairs Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
Effectiveness of Atorvastatin in Preventing Cerebrovascular Events After Flow Diverter Implantation
Conditions: Efficacy Endpoint: no New Cerebrovascular Adverse Events Within 1 Year; Safety Endpoint: no New Moderate or Serious Adverse Events Within 1 Year; All-cause Mortality Events (Within 1 Year); Incident Ischemic Stroke Events (Within 1 Year); New Hemorrhagic Stroke Events (Within 1 Year); New Stent Thrombosis Events (Within 1 Year); New Symptomatic Stenosis Events (Within 1 Year); Occurrence of In-stent Stenosis 12th ±1 Month Annual Angiographic Follow-up; Degree of In-stent Stenosis (as Measured by WASID Method) at the 12th ±1 Month Annual Angiographic Follow-up; Target Aneurysm Embolization Rate at 12±1 Month ...
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
ECC5004 DDI Study With Atorvastatin, Rosuvastatin, Digoxin and Midazolam in Healthy Participants
Conditions: Type 2 Diabetes Mellitus Interventions: Drug: ECC5004; Drug: Midazolam; Drug: Rosuvastatin; Drug: Digoxin; Drug: Atorvastatin Sponsors: Eccogene Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2024 Category: Research Source Type: clinical trials
A Study on How CagriSema Affects Levels of Atorvastatin and Warfarin in the Blood of Participants With Excess Body Weight
Conditions: Obesity Interventions: Drug: Cagrilintide; Drug: Semaglutide; Drug: Atorvastatin; Drug: Warfarin Sponsors: Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Evaluation of the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Diabetic Patients
Conditions: Diabetes Interventions: Drug: The combinations of 10 µg midazolam, 375 µg dabigatran etexilate, 10 µg pitavastatin, 50 µg rosuvastatin, and 100 µg atorvastatin were administered to diabetic patients on an empty stomach. Sponsors: Peking University Third Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials
Efficacy, Safety and Cost-efficacy of a Pre-emptive Genotyping Strategy in Patients Receiving Statins
Conditions: Cardiovascular Diseases; Dyslipidemias; Statin Adverse Reaction; Pharmacogenic Myopathy Interventions: Other: Preemptive pharmacogenetic atorvastatin dose based on CPIC guidelines; Other: Preemptive pharmacogenetic simvastatin dose based on CPIC guidelines; Other: Preemptive pharmacogenetic pitavastatin dose based on CPIC guidelines; Other: Preemptive pharmacogenetic rosuvastatin dose based on CPIC guidelines; Other: Preemptive pharmacogenetic pravastatin dose based on CPIC guidelines; Other: Preemptive pharmacogenetic lovastatin dose based on CPIC guidelines; Other: Preemptive pharmacogenetic fluvastatin dose ...
Source: ClinicalTrials.gov - February 16, 2024 Category: Research Source Type: clinical trials
Prophylactic Treatment With Atorvastatin for Episodic Migraine.
Conditions: Episodic Migraine Interventions: Drug: Atorvastatin 40mg; Drug: Placebo; Drug: Atorvastatin 20mg Sponsors: St. Olavs Hospital; Haukeland University Hospital; Oslo University Hospital; University Hospital of North Norway; University Hospital, Akershus; Ullevaal University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials